Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus and rheumatoid arthritis. Report of a case

Authors

  • Erik Lester Dávila-Alcalá Universidad Central de Venezuela, Hospital Universitario de Caracas, Caracas, Bolivarian Republic of Venezuela
  • Diana de Oliveira Escuela de Medicina Luis Razetti, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Bolivarian Republic of Venezuela
  • Rocío Iglesias-Fortes Escuela de Medicina Luis Razetti, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Bolivarian Republic of Venezuela
  • Fabian Zanella Universidad Central de Venezuela, Hospital Universitario de Caracas, Caracas, Bolivarian Republic of Venezuela

DOI:

https://doi.org/10.32818/reccmi.a2n2a10

Keywords:

thrombotic thrombocytopenic purpura, systemic lupus erythematosus, rheumatoid arthritis, hematological emergency

Abstract

Thrombotic thrombocytopenic purpura (TTP) was first described in the 1970-1980s, it is characterized by an intravascular aggregation process, produced by the deficiency of the metalloproteinase ADAMTS 13. It represents a rare hematological disorder, which has an incidence of 4 cases per million inhabitants per year. Treatment with plasmatic sparing has led to a fundamental change in the clinical course of adult patients with TTP. However, prolonged follow-up has revealed a progressively increasing rate of relapse.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Quirós Bonilla C, Aragón González M. Púrpura Trombocitopénica Trombótica (Reporte del primer caso clínico en Costa Rica donde se demuestra la presencia de inhibidores ADAMTS13). Revista Médica de Costa Rica y Centroamérica. 2014;71(612):723-8.

Bennett CL, Djulbegovic B. Thrombotic thrombocytopenic purpura: gaining knowledge. The Lancet Haematology. 2016;3(5):e210-e1.

Boyero RG, Esteve EM, Esteve MM, Perseguer MMM, Buades JM, Fabregat JB, et al. Lupus eritematoso sistémico y púrpura trombótica trombocitopénica: un caso refractario sin actividad lúpica asociada. Reumatol Clinica. 2013;9(6):373-5.

Pardo JMT, Murgado KN, Gómez JJ. Púrpura trombótica trombocitopénica y lupus eritematoso sistémico: descripción de un caso. Análisis desde atención primaria. Gaceta Médica de Bilbao. 2013;110(1):14-7.

Trice JM, Pinals RS, Plitman GI. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis. Arch Intern Med. 1983 Jul;143(7):1487-8.

Téllez-Hinojosa C, Vázquez-Mellado A, Gómez-Almaguer D. Thrombotic thrombocytopenic purpura. Medicina Universitaria. 2015;17(69):234-9. doi: https://doi.org/10.1016/j.rmu.2015.10.001.

Jamme M, Rondeau E. The PLASMIC score for thrombotic thrombocytopenic purpura. The Lancet Haematology. 2017;4(4):e148-e9.

Contreras E, de la Rubia J, del Río-Garma J, Díaz-Ricart M, García-Gala JM, Lozano M. Guía diagnóstica y terapéutica de las microangiopatías trombóticas del Grupo Español de Aféresis. Medicina Clínica. 2015;144(7):331.e1-.e13. doi: https://doi.org/10.1016/j.medcli.2014.09.013.

Published

2017-08-31

How to Cite

1.
Dávila-Alcalá EL, Oliveira D de, Iglesias-Fortes R, Zanella F. Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus and rheumatoid arthritis. Report of a case. Rev Esp Casos Clin Med Intern [Internet]. 2017 Aug. 31 [cited 2024 Dec. 26];2(2):89-90. Available from: https://www.reccmi.com/RECCMI/article/view/165